Improving the measurement and staging of lymphoma using advanced imaging techniques
Models and methods for automatically measuring disease body-wide and staging disease via FDG-PET/CT in Lymphoma
['FUNDING_R01'] · UNIVERSITY OF PENNSYLVANIA · NIH-10893984
This study is working on new ways to use advanced imaging techniques to help doctors better diagnose and monitor diffuse large B-cell lymphoma (DLBCL), so that patients like you can receive more accurate treatment plans.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF PENNSYLVANIA (nih funded) |
| Locations | 1 site (PHILADELPHIA, UNITED STATES) |
| Trial ID | NIH-10893984 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the ability to diagnose and monitor diffuse large B-cell lymphoma (DLBCL) through advanced imaging techniques like FDG-PET/CT. It aims to develop automated methods for accurately identifying and analyzing anatomical structures and disease areas in medical images, which is crucial for effective treatment planning. By creating a comprehensive approach to image segmentation that works across the entire body, the research seeks to provide more precise disease quantification and staging. Patients with DLBCL will be the primary focus, benefiting from improved diagnostic accuracy and treatment strategies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with diffuse large B-cell lymphoma (DLBCL) who are 21 years or older.
Not a fit: Patients with other types of lymphoma or those under 21 years old may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate diagnosis and monitoring of lymphoma, ultimately improving treatment outcomes for patients.
How similar studies have performed: Previous research in quantitative radiology has shown promise in improving diagnostic techniques, suggesting that this approach could yield significant advancements in lymphoma treatment.
Where this research is happening
PHILADELPHIA, UNITED STATES
- UNIVERSITY OF PENNSYLVANIA — PHILADELPHIA, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: UDUPA, JAYARAM K — UNIVERSITY OF PENNSYLVANIA
- Study coordinator: UDUPA, JAYARAM K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.